2024 Recipients of NMD4C and MDC Neuromuscular Fellowship Funding Competition

Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2024 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in NMD research and clinical fellowships in neuromuscular medicine and electromyography! NMD4C and MDC are committed to empowering the next generation of early-career researchers and clinicians in building successful careers in neuromuscular disease (NMD) research and clinical practice to improve neuromuscular care, research, treatment, and health outcomes for all Canadians. 


The 2024 competition provides salary support for two early-career scientists to conduct postdoctoral studies in laboratories focused on NMD research, and three early-career neurologists to participate in neuromuscular medicine and electromyography training programs. Successful applicants receive $40 000 in funding over a one-year period for postdoctoral fellowships, and $80 000 in funding over a one-year period for clinical fellowships. Since 2022, this competition has provided $1 million in funding to support neuromuscular postdoctoral researchers and clinical fellows in Canada, made possible by generous supporters of MDC, with one clinical fellow each year by the Canadian Society for Clinical Neurophysiologists. 


This competition involves an extensive review by leading Canadian neuromuscular researchers and clinicians to ensure the top-ranked candidates are selected for this funding opportunity.  From the entire neuromuscular community, congratulations to all 2024 recipients! 

Read the full press release from MDC


Postdoctoral Fellowship Recipients:

Cedrik Happi Mbakam

Dr. Cedrik Happi-Mbakam SickKids Hospital, Toronto, ON

Yassin Ouhaddi

Dr. Yassine Ouhaddi Centre de recherche du CHU Sainte-Justine, Montreal, QC








Learn more about the 2024 postdoctoral fellows and their research projects. 


Clinical Fellowship Recipients

Yiu-Chia Chang

Dr. Yiu-Chia Chang University of Western Ontario, London, ON

Mark Krongold

Dr. Mark Krongold University of British Columbia, Vancouver, BC

Bram De Wel

Dr. Bram De Wel University of Calgary, Calgary, AB








Learn more about the 2024 clinical fellows. 

Congratulations to the 2024 neuromuscular clinical and post-doctoral fellowship recipients. Photos of the fellows with information about their research insitutions.

Read next...

Spinal muscular atrophy outcome measures training registration open for December 3rd event.

Spinal Muscular Atrophy Outcome Measures Workshop (English Language)

The NMD4C will be hosting an English-language interactive training workshop on standardizing assessment practices in SMA outcome measures. 

Canadian Neuromuscular Community of Practice

NMD4C Launch Survey to Assess Familiarity and Experience in Outcome Measures in NMDs

As we anticipate novel treatments for other neuromuscular conditions, we would like to understand your familiarity and experience with the outcome measures in clinical trials underway or for treatments for NMDs approved in other jurisdictions through a short survey.


Dr. Cynthia Gagnon Receives 2024 Steinert Award, IDMC-15 Meeting to Take Place in Saguenay 

We are pleased to share that NMD4C steering committee member Dr. Cynthia Gagnon was honoured with a Steinert Award at the recent International Myotonic Dystrophy Consortium Meeting (IDMC-14) in Nijmegen, Netherlands! 

2024 Dr David Green Award winners from MDC

NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards

We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.

NMD4C logo with text reading 'Canadian neuromuscular clinical trials network', MDC and IMHA logos at bottom.

NMD4C Launch Canadian Neuromuscular Clinical Trial Network

We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.

Event organizers and participants from SMA outcome measures training, March 2024 in Quebec.

Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network

This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.